CapWealth Advisors LLC Acquires 9,430 Shares of CVS Health Corporation $CVS

CapWealth Advisors LLC grew its holdings in shares of CVS Health Corporation (NYSE:CVS) by 3.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 328,339 shares of the pharmacy operator’s stock after buying an additional 9,430 shares during the period. CVS Health makes up 1.8% of CapWealth Advisors LLC’s investment portfolio, making the stock its 22nd largest holding. CapWealth Advisors LLC’s holdings in CVS Health were worth $26,057,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Davis Selected Advisers boosted its holdings in shares of CVS Health by 11.9% during the 4th quarter. Davis Selected Advisers now owns 12,760,511 shares of the pharmacy operator’s stock worth $1,012,675,000 after buying an additional 1,356,870 shares in the last quarter. Robertson Stephens Wealth Management LLC raised its position in shares of CVS Health by 14.4% during the fourth quarter. Robertson Stephens Wealth Management LLC now owns 5,105 shares of the pharmacy operator’s stock worth $405,000 after purchasing an additional 641 shares during the period. Danske Bank A S raised its position in shares of CVS Health by 13.9% during the fourth quarter. Danske Bank A S now owns 928,462 shares of the pharmacy operator’s stock worth $73,683,000 after purchasing an additional 113,009 shares during the period. Citizens Business Bank acquired a new position in shares of CVS Health during the fourth quarter worth approximately $585,000. Finally, Oppenheimer & Co. Inc. raised its position in shares of CVS Health by 7.9% during the fourth quarter. Oppenheimer & Co. Inc. now owns 38,454 shares of the pharmacy operator’s stock worth $3,052,000 after purchasing an additional 2,811 shares during the period. 80.66% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other CVS Health news, EVP Tilak Mandadi sold 69,551 shares of the company’s stock in a transaction on Friday, May 8th. The stock was sold at an average price of $89.58, for a total value of $6,230,378.58. Following the completion of the transaction, the executive vice president owned 10,133 shares in the company, valued at $907,714.14. This represents a 87.28% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.85% of the company’s stock.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CVS. Barclays upped their target price on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Wells Fargo & Company upped their target price on CVS Health from $102.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, May 8th. JPMorgan Chase & Co. upped their target price on CVS Health from $101.00 to $111.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. UBS Group upped their target price on CVS Health from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, Royal Bank Of Canada upped their target price on CVS Health from $93.00 to $107.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $98.08.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS Health and WGU launched an online pre-pharmacy degree program aimed at building a pipeline of future pharmacists nationwide, which could help address labor shortages and support CVS’s retail pharmacy operations. CVS Health(R) and WGU Launch Online Pre-Pharmacy Degree Program for Future Pharmacists Nationwide
• Positive Sentiment: CVS also backed EnsembleIQ’s campaign supporting retail pharmacy as a way to help fill healthcare gaps, reinforcing CVS’s role in community pharmacy and care access. EnsembleIQ’s DSN, a Trusted Source in the Community Pharmacy Space, Launches Campaign in Support of Retail Pharmacy Filling Health Care Gaps
• Positive Sentiment: CVS Health published a study showing many Medicare members struggle with digital health literacy, which supports the company’s push to invest in digital tools and member engagement. CVS Health study reveals a need for greater digital health literacy for Medicare members

CVS Health Trading Down 1.9%

NYSE CVS opened at $94.18 on Wednesday. The firm has a market capitalization of $120.16 billion, a P/E ratio of 41.49, a PEG ratio of 0.94 and a beta of 0.60. The business has a fifty day simple moving average of $79.39 and a 200 day simple moving average of $78.76. CVS Health Corporation has a 12 month low of $58.50 and a 12 month high of $98.43. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, May 6th. The pharmacy operator reported $2.57 EPS for the quarter, beating analysts’ consensus estimates of $2.21 by $0.36. The business had revenue of $100.43 billion during the quarter, compared to analyst estimates of $94.99 billion. CVS Health had a return on equity of 11.88% and a net margin of 0.72%.CVS Health’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.25 EPS. CVS Health has set its FY 2026 guidance at 7.300-7.500 EPS. On average, analysts predict that CVS Health Corporation will post 7.44 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, May 4th. Investors of record on Thursday, April 23rd were given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s dividend payout ratio is presently 117.18%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.